via AI.Nony.Mous
Researchers from the University of Tsukuba and IBM Research have developed a self-administered mobile application that analyzes speech data as an automatic screening tool for the early detection of Alzheimer’s disease. Using automatic speech recognition, the proposed mobile application reliably estimates the degree of language impairments and detects Alzheimer’s disease in its prodromal stage.
Alzheimer’s disease (AD) is the most common form of dementia. It is important to start intervention from an early stage, e.g., the mild cognitive impairment (MCI) stage, to prevent or delay the progression of AD. For the early detection of AD and MCI, there is a growing need to develop user-friendly, self-administered screening tools for use in everyday life. Speech is a promising data source that can be used for developing such screening tools. Language impairments have been observed in the early stages of AD, and linguistic features characterizing these impairments have been used for the automatic detection of AD. However, the accuracy of automatic speech recognition used for converting human voice to text is generally of poorer quality in the case of elderly people than for people from other age groups, posing a challenge for developing an automatic tool.
Herein, researchers developed a prototype of a self-administered mobile application to help in the early detection of AD and MCI. Using this application, researchers collected and analyzed speech data of five cognitive tasks from 114 participants, including AD patients, MCI patients, and cognitively normal participants. The tasks were based on neuropsychological assessments used for dementia screening and included picture description and verbal fluency tasks. The results demonstrate that the degree of language impairments assessed by linguistic features, particularly those related to the semantic aspects (e.g., informativeness and vocabulary richness), could be reliably estimated at poor speech recognition accuracy. Moreover, by combining these linguistic features with acoustic and prosodic features of the participant’s voice, machine learning models could reliably detect MCI and AD, showing 88% and 91% accuracy, respectively.
To the best of our knowledge, this is the first study to show the feasibility of an automatic, self-administered screening tool for detecting AD and MCI by reliably capturing language impairments even from the speech data obtained under poor automatic speech recognition accuracy conditions. The proposed tool may help increase the access to screening tools for the early detection of AD.
Original Article: Self-Administered Mobile Application to Detect Alzheimer’s Disease Using Speech Data
More from: University of Tsukuba | IBM Research
The Latest Updates from Bing News
Go deeper with Bing News on:
Alzheimer’s disease detection
- Rising concerns: Dementia and Alzheimer's disease among diabetic patients in India
India has faced a rise in diabetes-linked dementia and Alzheimer's. Individuals with diabetes are at higher risk due to factors like high blood sugar and insulin resistance. Patient stories highlight ...
- New Alzheimer’s drugs give Iowa patients 'genuine hope,' Des Moines doctor says
Broadlawns Medical Center is the only provider in the area treating patients with Leqembi and will soon carry Kisunla.
- Healthcare Headlines: EU Approves GSK's RSV Shot, Eisai and Biogen Face Alzheimer Drug Rejection, WHO Fights Polio in Gaza
This summary covers the latest health news, including the EU's approval of GSK's RSV vaccine for adults aged 50-59, the rejection of Eisai and Biogen's Alzheimer's drug, WHO's shipment of polio ...
- Scientists discover how neurons age, offering hope for early detection of brain diseases
Researchers from King’s College London have made an important discovery about how different parts of nerve cells (neurons) age. This finding could help in early detection of neurodegenerative diseases ...
- RetiSpec secures $13.8 million Series A to detect Alzheimer’s early through retinal imaging
Founded in 2016, RetiSpec says its artificial intelligence (AI)-powered eye test aims to predict amyloid burden, a “core biomarker” of Alzheimer’s disease, at the point-of-care. RetiSpec says it is ...
Go deeper with Bing News on:
Alzheimer’s
- Less than 100 days away from Bainbridge's Walk to End Alzheimers
Jake Mintz & Jordan Shusterman talk some trade deadline deals, Dylan Cease's no-hitter for the Padres and make their picks for The Good, The Bad & The Uggla. Science says our subjective age influences our health and well-being.
- Study finds factors that help some people resist cognitive decline in Alzheimer's
Scientists have identified several factors that appear to influence an individual’s resilience to dementia after studying how specific cells and circuits become vulnerable to disease.